X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $367.32 million. The enterprise value is $191.60 million.
Important Dates
The last earnings date was Tuesday, March 17, 2026, before market open.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 90.92 million shares outstanding. The number of shares has increased by 531.04% in one year.
| Current Share Class | 90.92M |
| Shares Outstanding | 90.92M |
| Shares Change (YoY) | +531.04% |
| Shares Change (QoQ) | +155.49% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 62.20% |
| Float | 64.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.46 |
| Forward PS | 44.64 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.16, with a Debt / Equity ratio of 0.41.
| Current Ratio | 10.16 |
| Quick Ratio | 9.84 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.00 |
Financial Efficiency
Return on equity (ROE) is -75.99% and return on invested capital (ROIC) is -583.96%.
| Return on Equity (ROE) | -75.99% |
| Return on Assets (ROA) | -22.85% |
| Return on Invested Capital (ROIC) | -583.96% |
| Return on Capital Employed (ROCE) | -30.18% |
| Weighted Average Cost of Capital (WACC) | 7.18% |
| Revenue Per Employee | $780,289 |
| Profits Per Employee | -$1.76M |
| Employee Count | 45 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, XFOR has paid $41,000 in taxes.
| Income Tax | 41,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.01% in the last 52 weeks. The beta is 0.46, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -50.01% |
| 50-Day Moving Average | 3.70 |
| 200-Day Moving Average | 3.25 |
| Relative Strength Index (RSI) | 52.60 |
| Average Volume (20 Days) | 545,732 |
Short Selling Information
The latest short interest is 3.50 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 3.50M |
| Short Previous Month | 3.46M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 5.41% |
| Short Ratio (days to cover) | 5.75 |
Income Statement
In the last 12 months, XFOR had revenue of $35.11 million and -$79.20 million in losses. Loss per share was -$1.87.
| Revenue | 35.11M |
| Gross Profit | 29.36M |
| Operating Income | -79.88M |
| Pretax Income | -79.16M |
| Net Income | -79.20M |
| EBITDA | -78.61M |
| EBIT | -79.88M |
| Loss Per Share | -$1.87 |
Full Income StatementBalance Sheet
The company has $253.00 million in cash and $77.29 million in debt, with a net cash position of $175.71 million or $1.93 per share.
| Cash & Cash Equivalents | 253.00M |
| Total Debt | 77.29M |
| Net Cash | 175.71M |
| Net Cash Per Share | $1.93 |
| Equity (Book Value) | 186.29M |
| Book Value Per Share | 2.05 |
| Working Capital | 235.82M |
Full Balance SheetCash Flow
| Operating Cash Flow | -85.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.28M |
| Net Borrowing | n/a |
| Free Cash Flow | -85.62M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
Gross margin is 83.60%, with operating and profit margins of -227.50% and -225.55%.
| Gross Margin | 83.60% |
| Operating Margin | -227.50% |
| Pretax Margin | -225.44% |
| Profit Margin | -225.55% |
| EBITDA Margin | -223.87% |
| EBIT Margin | -227.50% |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -531.04% |
| Shareholder Yield | -531.04% |
| Earnings Yield | -21.56% |
| FCF Yield | -23.31% |
Analyst Forecast
The average price target for XFOR is $25.20, which is 523.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.20 |
| Price Target Difference | 523.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 75.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
XFOR has an Altman Z-Score of -2.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.09 |
| Piotroski F-Score | 3 |
